Cargando…

ELEVATED INTERLEUKIN-6 LEVELS IN COVID-19-INFECTED PATIENTS ARE ASSOCIATED WITH MAJOR ADVERSE CARDIAC EVENTS AND/OR MORTALITY

Detalles Bibliográficos
Autores principales:	Nguyen, Nicholas, Ukoha, Chijioke, Ikram, Farukh, Patel, Chirag, Nguyen, Hao, Hoang, Lawrence, Acharya, Priyanka, Dhillon, Anmol, Sidhu, Manavjot
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Cardiology Foundation. Published by Elsevier Inc. 2021
Materias:	Spotlight on Special Topics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091397/ http://dx.doi.org/10.1016/S0735-1097(21)04498-3

Ejemplares similares

TROPONIN-I PREDICTS MAJOR ADVERSE CARDIOVASCULAR EVENTS AND RISK OF MORTALITY IN COVID-19 PATIENTS
por: Patel, Chirag, et al.
Publicado: (2021)

Relation of interleukin-6 levels in COVID-19 patients with major adverse cardiac events
por: Nguyen, Nicholas, et al.
Publicado: (2021)

BRADYARRHYTHMIAS AND MORTALITY IN COVID-19 PATIENTS
por: Hoang, Lawrence, et al.
Publicado: (2021)

ATRIAL FIBRILLATION AND MAJOR ADVERSE CARDIOVASCULAR EVENTS AMONG HOSPITALIZED COVID-19 PATIENTS
por: Aten, Kristopher, et al.
Publicado: (2022)

EFFECTS OF ELEVATED TROPONIN ON MORTALITY IN HOSPITALIZED COVID-19 PATIENTS WITH AND WITHOUT CORONARY ARTERY DISEASE
por: Zhao, Yi, et al.
Publicado: (2022)

BODY MASS INDEX AS A PREDICTOR OF MORTALITY IN PATIENTS ADMITTED WITH COVID-19, A RETROSPECTIVE STUDY
por: Abualfoul, Mujahed, et al.
Publicado: (2022)

SOCIAL DETERMINANTS OF MORTALITY FROM COVID-19, A RETROSPECTIVE STUDY OF 6,000 PATIENTS
por: Abualfoul, Mujahed, et al.
Publicado: (2022)

AGE AS A PREDICTOR OF MORTALITY IN PATIENTS ADMITTED WITH COVID-19, A RETROSPECTIVE STUDY OF 6,000 PATIENTS
por: Abualfoul, Mujahed, et al.
Publicado: (2022)

ATRIAL FIBRILLATION AND MORTALITY IN COVID-19 PATIENTS
por: Wang, Lucas, et al.
Publicado: (2022)

CRITICALLY ILL COVID-19 PATIENTS AND THERAPEUTIC ANTICOAGULATION WITH HEPARIN
por: Vu, Michael, et al.
Publicado: (2022)

INCIDENCE OF MAJOR ADVERSE CARDIAC EVENTS AT 6-MONTHS FOLLOW-UP IN COVID-19 POSITIVE VERSUS COVID-19 NEGATIVE PATIENTS
por: Arman, Huseyin Emre, et al.
Publicado: (2023)

RIGHT VENTRICULAR DYSFUNCTION IN PATIENTS WITH COVID-19 INFECTION: A META-ANALYSIS
por: Mazur, Jan, et al.
Publicado: (2021)

CLINICAL IMPACT AND PREDICTORS OF TROPONIN ELEVATION IN PATIENTS WITH COVID-19
por: Case, Brian, et al.
Publicado: (2021)

PREDICTIVE VALUE OF TROPONIN, NTPROBNP AND SODIUM ON ADVERSE CLINICAL OUTCOMES IN COVID-19
por: Roman, Aida, et al.
Publicado: (2021)

CARDIAC COMPLICATIONS FOLLOWING REPEATED DOSES OF COVID-19 VACCINES: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Le, Trang Thi Bich, et al.
Publicado: (2023)

CLINICAL OUTCOMES AND PREDICTORS OF COVID-19 PATIENTS WITH TROPONIN ELEVATION AND CONCOMITANT RENAL DYSFUNCTION
por: Case, Brian, et al.
Publicado: (2021)

TROPONIN ELEVATION AS A MANIFESTATION OF COVID-19 MYOCARDIAL INFLAMMATION ASSOCIATED WITH INCREASED MORTALITY
por: Limaye, Sneha, et al.
Publicado: (2022)

CORONARY ARTERY CALCIFICATION HERALDS ADVERSE CLINICAL OUTCOMES IN PATIENTS HOSPITALIZED FOR COVID-19
por: Shabbir, Muhammad Asim, et al.
Publicado: (2021)

ELEVATED BLOOD VISCOSITY PREDICTS A HIGHER MORTALITY AMONG HOSPITALIZED PATIENTS WITH COVID-19
por: Choi, Daein, et al.
Publicado: (2022)

ELEVATION OF NT-PROBNP LEVEL IS ASSOCIATED WITH HIGHER IN-HOSPITAL MORTALITY FOR COVID-19 IN ETHNIC MINORITY COMMUNITY
por: Jadhav, Preeti, et al.
Publicado: (2021)

PROGNOSTIC VALUE OF ELEVATED HIGH-SENSITIVITY TROPONIN LEVEL IN COVID-19 ASSOCIATED HOSPITALIZATIONS IN THE SOUTH BRONX
por: Yue, Bing, et al.
Publicado: (2021)

COMPARISON OF PROGNOSTIC SIGNIFICANCE OF TROPONIN I ELEVATION TO OTHER BIOMARKERS IN PATIENTS HOSPITALIZED WITH COVID 19 INFECTION
por: Jayanna, Manju Bengaluru, et al.
Publicado: (2021)

PRESENTATION DELAY AMONG PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION OUTSIDE OF A COVID-19 HOT ZONE
por: McNamara, David, et al.
Publicado: (2021)

CARDIOVASCULAR PREDICTORS OF ADVERSE OUTCOMES IN RACIALLY DIVERSE PATIENTS DIAGNOSED WITH COVID-19 INFECTION - AN EARLY, INNER CITY EXPERIENCE
por: Quelal, Karol, et al.
Publicado: (2021)

ACUTE ST ELEVATION MYOCARDIAL INFARCTION (STEMI) MANAGEMENT DURING COVID-19 ERA: AN INDIAN SURVEY REPORT BY 1083 CARDIOLOGISTS
por: Ponde, Chandrashekar, et al.
Publicado: (2021)

TROPONIN ELEVATION AS A PREDICTOR FOR OUTCOMES OF PATIENTS DIAGNOSED WITH COVID 19 INFECTION IN A LARGE PUBLIC HOSPITAL IN THE CHICAGO AREA
por: Quelal, Karol, et al.
Publicado: (2021)

EFFECT OF COVID-19 ON PRESENTATION, MANAGEMENT AND SURVIVAL OF ST ELEVATION MYOCARDIAL INFARCTION (STEMI) PATIENTS IN A SINGLE UK CENTRE
por: Perera, Sachintha, et al.
Publicado: (2021)

CLINICAL PROFILE AND EARLY IN-HOSPITAL OUTCOMES OF COVID-19 PATIENTS WITH ST ELEVATION MYOCARDIAL INFARCTION: THE PHILIPPINE HEART CENTER EXPERIENCE
por: Denila, Rachel Ann, et al.
Publicado: (2022)

INITIAL SINGLE CENTER ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION EXPERIENCE IN NEW YORK BEFORE AND DURING THE COVID-19 PANDEMIC
por: Medranda, Giorgio, et al.
Publicado: (2021)

A SYSTEMATIC REVIEW OF MYOCARDITIS FOLLOWING COVID-19 VACCINATION
por: Dong, Vinh S., et al.
Publicado: (2022)

AORTIC VALVE PROSTHESES, ICDS, AND CORONARY DRUG-ELUTING STENTS: CHANGES IN REPORTED RATES OF ADVERSE EVENTS DURING THE COVID-19 PANDEMIC
por: Zhou, Elsa, et al.
Publicado: (2022)

CHARACTERIZATION OF THE FIRST 391 REPORTS OF MYOCARDITIS AFTER MRNA COVID-19 VACCINES SUBMITTED TO THE VACCINE ADVERSE EVENT REPORTING SYSTEM - UNITED STATES
por: Rodriguez-Nava, Guillermo, et al.
Publicado: (2022)

A SYSTEMATIC REVIEW AND META ANALYSIS OF THE EVIDENCE FROM THE PUBLISHED CASE REPORTS AND VACCINE ADVERSE EVENTS REPORTING SYSTEMS FOR THE MYOCARDITIS FOLLOWING COVID-19 VACCINATION
por: Mehta, Ashwani, et al.
Publicado: (2022)

SITE-LEVEL VARIABILITY IN THE PROCESSES OF CARE OVER TIME AMONG PATIENTS WITH COVID-19 AND ELEVATED TROPONIN: INSIGHTS FROM THE AMERICAN HEART ASSOCIATION'S CVD COVID-19 REGISTRY
por: Sammour, Yasser, et al.
Publicado: (2022)

IMPACT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON SHORT-TERM OUTCOME IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION DURING COVID-19 PANDEMIC: INSIGHTS FROM THE INTERNATIONAL MULTICENTER ISACS-STEMI REGISTRY
por: De Luca, Giuseppe, et al.
Publicado: (2022)

CARDIAC INVOLVEMENT IN COVID-19: INSIGHTS FROM A SAFETY NET URBAN HOSPITAL
por: Garcia, Mariana, et al.
Publicado: (2021)

ECHOCARDIOGRAPHIC AND BIOMARKER PREDICTORS FOR IN-HOSPITAL MORTALITY IN COVID-19 DISEASE
por: Gomez, Joanne Michelle D., et al.
Publicado: (2021)

ASSOCIATION BETWEEN IN-HOSPITAL MORTALITY AND ACE/ARB INHIBITOR USAGE
por: Ruge, Max, et al.
Publicado: (2022)

A NOVEL APPROACH TO TEACHING CORONARY ANGIOGRAPHY USING 3D-PRINTING
por: Sabbak, Nabil, et al.
Publicado: (2022)

OUTPATIENT CARDIAC MONITORING TO DETERMINE ARRHYTHMIC BURDEN AFTER COVID-19 HOSPITALIZATION
por: Beccarino, Nicholas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lu9edq9jpf5e9o5pukgmpjosrp